ZPD-20502-33944
3 vaccinations
5 coded responses
27 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 442 / OH
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 1 — Moderna
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-09
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-01-10
-
2021-01-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-01-14
- 2021-01-21
-
2021-01-28
Survey response — day 21, dose 1MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Dose 2 — Moderna
- 2021-02-04
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Cold sweat — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tirednessFree text: Cold sweatMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-20
-
2021-02-25
Survey response — day 21, dose 2MedDRA: Fatigue — Feeling: GoodFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-04
- 2021-03-13
- 2021-05-08
- 2021-08-05
-
2021-09-12
Dose 3 — Moderna
- 2021-10-25
-
2021-12-12
Survey response — 3 months, dose 3MedDRA: Bronchitis, Sinusitis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Acute sinus infection and bronchitisMedDRA releases: 2024-11 · check-in free text available
-
2021-12-12
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-14
-
2022-09-12
Survey response — 12 months, dose 3MedDRA: COVID-19, Fatigue, Headache, Pain, Suspected COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: COVID 8/22 Ongoing fatigue and body aches prior after suspected COVID dx 12/21MedDRA releases: 2024-11 · check-in free text available
-
2022-09-12
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-13
- 2022-09-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-07 | Moderna | |
| 2 | 2021-02-04 | Moderna | |
| 3 | 2021-09-12 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-12 | Unsuccessful | |
| 2022-09-12 | Unsuccessful |
Free text
Release 2 — day 21, dose 1
Symptoms: Fatigue
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Cold sweat
Release 4 — day 21, dose 2
Symptoms: Fatigue
Release 10 — 3 months, dose 3
Symptoms: Acute sinus infection and bronchitis
Release 12 — 12 months, dose 3
Symptoms: COVID 8/22 Ongoing fatigue and body aches prior after suspected COVID dx 12/21
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SD | Suspected COVID-19 | · | · | ✓ |
| SRO | Cold sweat | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release